B-Cell Activation Gene Signature in Blood and Liver of Hepatitis B e Antigen–Positive Patients With Immune Active Chronic Hepatitis B

Author:

Osmani Zgjim1ORCID,Beudeker Boris J B1,Groothuismink Zwier M A1,de Knegt Robert J1,Chung Raymond T2,Aerssens Jeroen3,Bollekens Jacques3,Janssen Harry L A14,Gehring Adam J56,Lauer Georg M7,Shalek Alex K789,van de Werken Harmen J G10,Boonstra Andre1ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology, Erasmus University Medical Center , Rotterdam , The Netherlands

2. Liver Center, Division of Gastroenterology and Liver Center, Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts

3. Clinical Translational Science Infectious Diseases, Janssen Research and Development , Beerse , Belgium

4. Toronto Centre for Liver Disease, Toronto General Hospital, University of Toronto

5. Toronto Centre for Liver Disease, Toronto General Hospital Research Institute, University Health Network

6. Department of Immunology, University of Toronto , Ontario , Canada

7. The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University

8. Institute for Medical Engineering and Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

9. Broad Institute of Massachusetts Institute of Technology and Harvard , Cambridge, Massachusetts

10. Department of Immunology, Erasmus University Medical Center , Rotterdam , The Netherlands

Abstract

Abstract Background Studies on chronic hepatitis B virus (HBV) infection have shown immune dysfunction involving multiple cell types, including T cells. B cells have been evaluated more recently, but in contrast to T cells, more pronounced activation of circulating B cells has been reported. To gain more insight into the activation status of B cells, we investigated gene profiles of B cells in the blood and liver of patients with chronic HBV. Methods RNA-sequencing and flow cytometric analysis was performed on peripheral blood B cells of patients with immune active chronic HBV, comparing them with samples from healthy controls. In addition, gene expression profiles of B cells in the liver were analyzed by bulk and single-cell RNA-seq. Results Our data show a distinctive B-cell activation gene signature in the blood of patients with immune active chronic HBV, characterized by a significant upregulation of immune-related genes. This peripheral activation profile was also observed in B cells from the liver by single-cell RNA-seq, with naive and memory B-cell subsets being the primary carriers of the signature. Conclusions Our findings suggest that B-cell gene profiles reflect responsiveness to HBV infection; these findings are relevant for clinical studies evaluating immunomodulatory treatment strategies for HBV.

Funder

Janssen Pharmaceuticals

Massachusetts General Hospital

Toronto Centre for Liver Disease

Canada Foundation for Innovation

National Institutes of Health

Break Through Cancer

Pew-Stewart Scholars Program

Foundation MIT

Wellcome Leap

Bill & Melinda Gates Foundation

Moore Foundation

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3